Cargando…
Psychotropic medication use in people living with severe and persistent mental illness in the Australian community: a cross-sectional study
BACKGROUND: Psychotropic polypharmacy and high-dose prescribing may play a role in therapy, however, with associated risks. The aim of this study was to describe current prescribing practices and use of four psychotropic medication groups (antipsychotics, antidepressants, mood stabilisers and benzod...
Autores principales: | Hu, Jie, McMillan, Sara S, Theodoros, Theo, Collins, Jack C, El-Den, Sarira, O’Reilly, Claire L, Wheeler, Amanda J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667665/ https://www.ncbi.nlm.nih.gov/pubmed/36380352 http://dx.doi.org/10.1186/s12888-022-04324-0 |
Ejemplares similares
-
Psychological distress in community-dwelling individuals living with severe and persistent mental illness
por: Collins, Jack C, et al.
Publicado: (2023) -
Pharmacists’ roles in supporting people living with severe and persistent mental illness: a systematic review protocol
por: El-Den, Sarira, et al.
Publicado: (2020) -
Experiences of goal planning in Australian community pharmacy settings for people experiencing mental illness: A qualitative study
por: Stewart, Victoria, et al.
Publicado: (2023) -
Bridging the gap between physical and mental illness in community pharmacy (PharMIbridge): protocol for an Australian cluster randomised controlled trial
por: Wheeler, Amanda J, et al.
Publicado: (2020) -
Implementing a randomised controlled trial through community pharmacies to support people living with severe and persistent mental illness: Lessons learnt during the COVID-19 pandemic
por: O'Reilly, Claire L., et al.
Publicado: (2023)